[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340521-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340521-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","size-and-suvmax-define-the-contribution-of-nodal-metastases-to-psa-in-oligorecurrent-prostate-cancer","Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer","","Background: Evaluate PSA decline after removal of isolated prostate cancer nodal metastases according to metastasis diameter/volume (PSA-density) and maximum standardized uptake value (SUVmax). Methods: Retrospective analysis of 83 patients with solitary nodal recurrence after radical prostatectomy undergoing PSMA radioguided salvage surgery. Multivariable linear regression correlated PSA decrease per metastasis with imaging and histopathologic long-axis diameter, estimated volume, and SUVmax. Results: Median PSA decrease 0.56 ng/mL; size thresholds for BCR exceeded ~2.2–2.5 mm depending on measurement. Conclusions: Metastasis diameter/volume and SUVmax correlate with PSA contribution.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/size-and-suvmax-define-the-contribution-of-nodal-metastases-to-psa-in-oligorecurrent-prostate-cancer/340521/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/size-and-suvmax-define-the-contribution-of-nodal-metastases-to-psa-in-oligorecurrent-prostate-cancer/340521.png","ImageObject",300,407,{"name":42,"@type":43},"Evangeline","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the study?","Question",{"text":63,"@type":64},"To quantify how PSA levels decrease after removal of isolated nodal metastases, and how this relates to metastasis size (diameter/volume) and SUVmax.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PSA contribution and metastasis size assessed?",{"text":68,"@type":64},"After PSMA-radioguided salvage surgery, PSA decrease after removal of each metastasis was correlated with measured long-axis diameter/estimated volume from imaging and histopathology, and with SUVmax.",{"name":70,"@type":61,"acceptedAnswer":71},"What factors were linked to biochemical recurrence detection?",{"text":72,"@type":64},"Diameter/volume and SUVmax correlated with the PSA contribution of metastatic tissue; very small metastases may generate too little PSA to reach biochemical recurrence thresholds.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340521,1790192894,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","DOI: 10.1002/pros.24806  \nORI G INA L ART I CLE  \nSize and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer  \nFabian Falkenbach MD1,2  | Marie‐Lena Schmalhofer MD3 | Zhe Tian MSc2 | Giovanni Mazzucato MD1,4  | Pierre I. Karakiewicz MD2 | Markus Graefen MD1 | Sophie Knipper MD1,5 | Lars Budäus MD, MA1,6 | Daniel Koehler MD3 |  \nTobias Maurer MD1,6  \n1Martini‐Klinik Prostate Cancer Center, University Medical Center Hamburg‐ Eppendorf, Hamburg, Germany  \n2Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, Québec, Canada 3Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg‐Eppendorf, Hamburg, Germany  \n4Department of Urology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy  \n5Department of Urology, Vivantes  \nKlinikum am Urban, Berlin, Germany 6Department of Urology, University Medical Center Hamburg‐Eppendorf, Hamburg, Germany  \nCorrespondence  \nFabian Falkenbach, MD, Martini‐Klinik Prostate Cancer Center, University Medical Center Hamburg‐Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.  \nEmail: [f.falkenbach@uke.de](f.falkenbach@uke.de)  \nAbstract  \nBackground: To evaluate how prostate‐specific antigen (PSA) levels decrease after removal of isolated prostate cancer (PCa) nodal metastases in relation to their diameter/volume (“PSA‐density of PCa‐metastases”) and maximum standardized uptake value (SUVmax) .  \nMethods: A total of 83 consecutive patients with solitary nodal recurrence after radical prostatectomy who underwent prostate‐specific membrane antigen‐ radioguided salvage surgery were retrospectively analyzed. Using multivariable linear regression models, the PSA‐decrease after removal of each PCa‐metastases (=PSA‐contribution of each PCa‐metastases) was correlated with the long axis diameter/estimated volume and the SUVmax of each removed metastasis. Sizes were measured by imaging and histopathologic examination.  \nResults: A total of 83 patients were included with a median (interquartile range [IQR]) PSA‐decrease of 0 . 56 [0 .22, 1 .31] ng/mL after salvage surgery. The median [IQR] long axis diameters in imaging and histopathological examination were 8.0 [6.0, 11.0] mm and 8 .4 [5 . 5, 11 . 1] mm, respectively. The median [IQR] estimated volumes were 0 . 13 [0 .05, 0 .32] cc (imaging) and 0 .05 [0 .02, 0 . 17] cc (pathology) . In multivariable linear regression analyses, the estimated PSA‐contribution ([95% confidence interval [CI]) of each millimeter of long axis diameter was 0.09 [0.03, 0.14] ng/mL (imaging) or 0 .08 [0 .03, 0 . 12] ng/mL (histology) . The minimum diameter for biochemical recurrence (PSA ≥ 0.2 ng/mL) was >2 .2 mm (imaging) or >2 . 5 mm (histology) . The estimated PSA‐contribution [95% CI] of each cc cancer volume was 1.23 [0 . 51, 1 .94] ng/mL (imaging) or 1 .46 [0 .40, 2 . 52] ng/mL (histology) . SUVmax as surrogate parameter for tissue composition was associated with increased PSA‐contribution of PCa‐metastases (+0 .03–0.05 ng/mL per unit increase) .  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2024 The Author(s) . The Prostate published by Wiley Periodicals LLC.  \nConclusions: The diameter/volume and SUVmax of metastatic tissue correlate with its contribution to PSA levels. Therefore, very small metastases may produce too little PSA for biochemical recurrence.  \nKEYWO R DS  \nlymph nodes, neoplasm staging, positron‐emission tomography, prostatic neoplasms, PSA  \n1 | INTRODUCTION  \nThere is ongoing controversy as to whether pelvic lymph node dissection (PLND) during radical prostatectomy (RP) can be omitted inpatients with nomogram‐derived risk above a certain threshold but with negative pros","cbCailHUTTEnvuyy","https://ap.wps.com/l/cbCailHUTTEnvuyy","pdf",811773,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Imaging sensitivity and micrometastases\n## PSA persistence and biochemical recurrence","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To quantify how PSA levels decrease after removal of isolated nodal metastases, and how this relates to metastasis size (diameter/volume) and SUVmax.\"},{\"question\":\"How were PSA contribution and metastasis size assessed?\",\"answer\":\"After PSMA-radioguided salvage surgery, PSA decrease after removal of each metastasis was correlated with measured long-axis diameter/estimated volume from imaging and histopathology, and with SUVmax.\"},{\"question\":\"What factors were linked to biochemical recurrence detection?\",\"answer\":\"Diameter/volume and SUVmax correlated with the PSA contribution of metastatic tissue; very small metastases may generate too little PSA to reach biochemical recurrence thresholds.\"}]","Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer | PDF",1790037061,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15a4fc4dcce065b17099e3d3d703264a.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8e2d9fdb4417214e32922b6769b8870.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a03f091413450059b84167cd3959ab36.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ceebdbe5bc6cd305c19fc66d0ec8f54.webp",980,1287]